<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Common occupational chemical exposures: General approach and management of selected exposures</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Common occupational chemical exposures: General approach and management of selected exposures</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Common occupational chemical exposures: General approach and management of selected exposures</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Vearrier, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert G Hendrickson, MD, FACMT, FAACT</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 14, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4225002400"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Occupational exposures to potentially hazardous chemicals can cause significant morbidity, both acute and chronic, and mortality. Patients who present to an acute care facility may be able to identify their toxic exposure; otherwise, the clinician may have to deduce the probable toxic exposure based on the patient's job description, workplace, and clinical manifestations.</p><p>This topic is an overview of the approach to exposures to common occupational chemicals. The following are discussed in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>Overview of occupational health (see  <a class="medical medical_review" href="/d/html/2749.html" rel="external">"Overview of occupational and environmental health"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Occupational rhinitis and lower airway conditions (see  <a class="medical medical_review" href="/d/html/7529.html" rel="external">"Occupational rhinitis"</a> and  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a> and  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a> and  <a class="medical medical_review" href="/d/html/4309.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Epidemiology, causes, and pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/14874.html" rel="external">"Imaging of occupational lung diseases"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Occupational risks to reproduction (see  <a class="medical medical_review" href="/d/html/111468.html" rel="external">"Occupational and environmental risks to reproduction in females: Specific exposures and impact"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Topical chemical burns and inhalational chemical injury (see  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a> and  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>)</p><p></p><p class="headingAnchor" id="H1768112755"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>In 2021, there were 37,441 occupational exposures reported to United States poison control centers, accounting for nearly 2 percent of all calls [<a href="#rid1">1</a>]. There were eight deaths attributed to unintentional occupational exposures. However, these data only include exposures that were called into a poison center and underestimates the actual number of workplace exposures in the United States. The US Department of Labor Bureau of Labor Statistics reported 50 deaths due to occupational inhalational exposures and five deaths due to ingestions in 2020 [<a href="#rid2">2</a>]. In that same year, 405,550 nonfatal exposures to harmful substances (including 3460 chemical burns and 9530 exposures to chemical products) resulted in missed workdays.</p><p>In the US from 2008 to 2018, patients with clinically significant occupational poisoning (CSOP; defined as moderate or severe clinical effects) were likely to be male and adults aged 18 to 59 [<a href="#rid3">3</a>]. The most common substances associated with CSOP (in order of decreasing frequency) were caustics, chlorines/hypochlorites, carbon monoxide, hydrocarbons, cleansers/detergents, ammonia, cement, hydrofluoric acid, chlorofluorocarbons, hydrochloric acid, disinfectants, hydrogen sulfide, simple asphyxiants, pyrethrins/pyrethroids, and toluene/xylene. The most common substances associated with fatal occupational poisonings (in order of decreasing frequency) were hydrogen sulfide, ammonia, carbon monoxide, simple asphyxiants, chlorines/hypochlorites, alkalis, pyrethrins/pyrethroids, toluene/xylene, methane, methylene chloride, chlorofluorocarbons, and hydrochloric acid. The most common routes of exposure were inhalational, dermal, and ocular. </p><p class="headingAnchor" id="H962458165"><span class="h1">INITIAL EVALUATION AND MANAGEMENT</span></p><p class="headingAnchor" id="H2135282364"><span class="h2">Prearrival preparation</span><span class="headingEndMark"> — </span>If the treating facility receives advance notice (eg, from emergency medical personnel or an employer), clinicians should prepare by:</p><p class="bulletIndent1"><span class="glyph">●</span>Searching the internet for the exposure product's Safety Data Sheet (SDS), which may provide information on the component substances, pH, expected toxicity, and patient management. If an SDS is not available, the nature of the workplace or industry may yield clues to the exposure. A medical toxicologist or poison control center can also provide advice regarding potential hazardous substances and management priorities. (See <a class="local">'Regional poison centers'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Setting up decontamination equipment and a treatment room appropriate for the reported exposure. Decontamination areas should have supplies and medications necessary to provide stabilization of a critically ill patient. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Donning necessary personal protective equipment (PPE). The level of PPE depends on the exposure and location of care. If the exposure is unknown, the Occupational Safety and Health Administration (OSHA) recommends a level of PPE that includes a powered air-purifying respirator, which is discussed separately. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Protection of clinicians'</a>.)</p><p></p><p class="headingAnchor" id="H2482417524"><span class="h2">Assess and stabilize ABCs</span><span class="headingEndMark"> — </span>The initial evaluation and management begin with assessing and stabilizing airway, breathing, and circulation (ABCs). In patients with caustic oropharynx exposure, we perform early tracheal intubation before progressive edema leads to complete obstruction and an airway crisis. (See  <a class="medical medical_review" href="/d/html/281.html" rel="external">"Airway management in the adult with direct airway trauma for emergency medicine and critical care", section on 'Guiding principle: Secure the airway early'</a>.)</p><p>Trauma resuscitation principles (eg, cervical spine immobilization) should be applied if there is concern for significant concomitant injury (eg, blast injury). (See  <a class="medical medical_review" href="/d/html/13854.html" rel="external">"Initial management of trauma in adults"</a>.)</p><p class="headingAnchor" id="H4260077664"><span class="h2">Decontamination</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dermal</strong> – Skin decontamination typically occurs after the ABCs are assessed but may need to be performed during the initial resuscitation in the critically ill patient. For most dermal exposures, removal of all clothing and copious washing or irrigation with soap and water is sufficient. Notable exceptions to water irrigation are dry lime and elemental metals, which must be removed manually since irrigation may cause caustic or exothermic injury. While some chemicals have specific preferred decontamination products  (<a class="graphic graphic_table graphicRef70216" href="/d/graphic/70216.html" rel="external">table 1</a>), decontaminate with soap and water until the preferred product is available. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Chemicals NOT treated with immediate water irrigation'</a>.)</p><p></p><p class="bulletIndent1">Contaminated clothing should be placed in plastic bags to avoid secondary exposure to health care personnel from off-gassing or caustic contamination. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Water irrigation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ocular</strong> – Decontamination of an ocular exposures  (<a class="graphic graphic_table graphicRef56411" href="/d/graphic/56411.html" rel="external">table 2</a>) requires copious irrigation to remove solid particulates and minimize caustic injury and is discussed separately. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Patient with eye exposure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal</strong> – Decontamination of the gastrointestinal tract is typically not indicated for workplace ingestions since most occupational hazards do not absorb to activated charcoal or are contraindications for gastric lavage or whole bowel irrigation (eg, toxic alcohols, caustics, hydrocarbons, metals). </p><p></p><p class="bulletIndent1">Notable exceptions that may benefit from gastrointestinal decontamination include organophosphates, paraquat, diquat, thallium, sodium monofluoroacetate, barium carbonate, vacor, and alpha-chloralose  (<a class="graphic graphic_table graphicRef97349" href="/d/graphic/97349.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/321.html" rel="external">"Gastrointestinal decontamination of the poisoned patient"</a> and  <a class="medical medical_review" href="/d/html/339.html" rel="external">"Organophosphate and carbamate poisoning", section on 'Decontamination'</a> and  <a class="medical medical_review" href="/d/html/337.html" rel="external">"Paraquat poisoning", section on 'Gastrointestinal decontamination'</a> and  <a class="medical medical_review" href="/d/html/94398.html" rel="external">"Overview of rodenticide poisoning", section on 'Known poison'</a>.)</p><p></p><p class="headingAnchor" id="H2192179340"><span class="h1">DIFFERENTIAL DIAGNOSIS BASED ON CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H2367548364"><span class="h2">General approach</span><span class="headingEndMark"> — </span>If an exposure is unknown, the toxin class may be suspected based on the following (see  <a class="medical medical_review" href="/d/html/324.html" rel="external">"General approach to drug poisoning in adults", section on 'Overview of approach'</a> and  <a class="medical medical_review" href="/d/html/13850.html" rel="external">"Initial management of the critically ill adult with an unknown overdose", section on 'Rapid first look: Examination, monitoring, and testing'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Toxidrome  (<a class="graphic graphic_table graphicRef71268" href="/d/graphic/71268.html" rel="external">table 4</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Characteristic odor  (<a class="graphic graphic_table graphicRef76045" href="/d/graphic/76045.html" rel="external">table 5</a>) </p><p class="bulletIndent1"><span class="glyph">●</span>Hyperthermia or hypothermia  (<a class="graphic graphic_table graphicRef55439" href="/d/graphic/55439.html" rel="external">table 6</a>) </p><p class="bulletIndent1"><span class="glyph">●</span>Changes in heart rate and blood pressure  (<a class="graphic graphic_table graphicRef51200" href="/d/graphic/51200.html" rel="external">table 7</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Changes in respiration  (<a class="graphic graphic_table graphicRef64012" href="/d/graphic/64012.html" rel="external">table 8</a>)</p><p></p><p>Most occupational exposures produce immediate symptoms. Notable exceptions that may present with delayed onset of symptoms include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Tracheobronchial and lung parenchymal injury due to inhalational exposure of a caustic with low water solubility (eg, chlorine, oxides of nitrogen, phosgene) may take hours to manifest. (See <a class="local">'Chlorines/hypochlorites'</a> below and <a class="local">'Phosgene'</a> below and  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ethylene glycol or methanol ingestion can take hours to manifest a metabolic acidosis. (See  <a class="medical medical_review" href="/d/html/336.html" rel="external">"Methanol and ethylene glycol poisoning: Pharmacology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inhaled or ingested methylene chloride. (See  <a class="medical medical_review" href="/d/html/322.html" rel="external">"Carbon monoxide poisoning"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A dilute hydrofluoric acid dermal exposure may result in delayed-onset soft tissue injury. Fingertip pain with mild erythema or whitish skin discoloration that starts several hours after cleaning product exposure should raise suspicion for hydrofluoric acid exposure. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Hydrofluoric (HF) acid'</a> and <a class="local">'Hydrofluoric acid'</a> below.)</p><p></p><p class="headingAnchor" id="H2082871326"><span class="h2">Specific clinical manifestations</span><span class="headingEndMark"> — </span>The presence and onset of clinical manifestations can also provide clues to the nature and extent of an exposure, such as the following:</p><p class="headingAnchor" id="H1380517977"><span class="h3">Altered mental status</span><span class="headingEndMark"> — </span>Occupational exposure to carbon monoxide, cyanide, hydrogen sulfide, hydrocarbons (eg, toluene, xylene), toxic alcohols, methylene chloride, arsenic, and simple asphyxiants can cause altered mental status. The specific exposure may be suspected based on the patient's job duties, workplace environment, and additional clinical manifestations, such as the following: </p><p class="bulletIndent1"><span class="glyph">●</span>Immediate onset of a metabolic acidosis and sudden loss of consciousness suggest poisoning with a cellular asphyxiant (eg, carbon monoxide, cyanide, hydrogen sulfide). (See  <a class="medical medical_review" href="/d/html/322.html" rel="external">"Carbon monoxide poisoning"</a> and  <a class="medical medical_review" href="/d/html/299.html" rel="external">"Cyanide poisoning"</a> and <a class="local">'Hydrogen sulfide'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Delayed onset of a metabolic acidosis suggests poisoning with a toxic alcohol or methylene chloride (an industrial solvent and a component of paint remover that is hepatically metabolized to carbon monoxide). (See  <a class="medical medical_review" href="/d/html/336.html" rel="external">"Methanol and ethylene glycol poisoning: Pharmacology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/322.html" rel="external">"Carbon monoxide poisoning"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Slurred speech, ataxia, or diplopia suggests a hydrocarbon ingestion. (See  <a class="medical medical_review" href="/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis", section on 'Hydrocarbon ingestion'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting and diarrhea suggest inorganic arsenic poisoning. Massive hemolysis suggests arsine gas poisoning.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A history of working in an enclosed space suggests simple asphyxia from accumulation of gasses. (See <a class="local">'Methane, propane, butane'</a> below.)</p><p></p><p>Altered mental status can also be related to nonoccupational etiologies, such as alcohol or drug intoxication  (<a class="graphic graphic_table graphicRef80618" href="/d/graphic/80618.html" rel="external">table 9</a>), hypoglycemia, or central nervous system lesions (eg, stroke, hemorrhage). (See  <a class="medical medical_review" href="/d/html/5104.html" rel="external">"Stupor and coma in adults", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/d/html/4824.html" rel="external">"Diagnosis of delirium and confusional states", section on 'Evaluation'</a>.)</p><p class="headingAnchor" id="H4090625804"><span class="h3">Dyspnea, cough, or wheezing</span><span class="headingEndMark"> — </span>Inhalational exposures can cause dyspnea, cough, or wheezing as a result of lower respiratory tract irritation/injury, bronchospasm, or immunologic (ie, sensitization) and nonimmunologic mechanisms. Inhaled chemicals with low water solubility predominantly cause lower respiratory tract injury.</p><p class="bulletIndent1"><span class="glyph">●</span>Caustic agents that can cause an inhalational injury include hydrofluoric acid, hydrochloric acid, chlorine, hypochlorites, sodium hydroxide, chloramine, oxides of nitrogen, and other volatile acids and bases. The general evaluation and management of irritant inhalational injuries are discussed separately. (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Many agents (eg, diisocyanates, chloramine)  (<a class="graphic graphic_table graphicRef66185" href="/d/graphic/66185.html" rel="external">table 10</a>) have been associated with occupational asthma. (See  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypersensitivity pneumonitis can be caused by chemicals  (<a class="graphic graphic_table graphicRef68812" href="/d/graphic/68812.html" rel="external">table 11</a>) or organic antigens. (See  <a class="medical medical_review" href="/d/html/4309.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Epidemiology, causes, and pathogenesis", section on 'Etiologic agents'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>"Metal fume fever" typically occurs in welders. Symptoms include cough, dyspnea, chest tightness, fevers, chills, malaise, headaches, and myalgias without significant radiographic pulmonary findings. (See <a class="local">'Zinc oxide fumes'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic or repeated exposure to many industrial substances can cause pneumoconioses (ie, interstitial lung diseases) or granulomatous disease. (See  <a class="medical medical_review" href="/d/html/4310.html" rel="external">"Approach to the adult with interstitial lung disease: Clinical evaluation"</a> and  <a class="medical medical_review" href="/d/html/4307.html" rel="external">"Asbestos-related pleuropulmonary disease"</a> and  <a class="medical medical_review" href="/d/html/4321.html" rel="external">"Silicosis"</a> and  <a class="medical medical_review" href="/d/html/4367.html" rel="external">"Chronic beryllium disease (berylliosis)"</a> and  <a class="medical medical_review" href="/d/html/4314.html" rel="external">"Flock worker's lung"</a>.)</p><p></p><p class="headingAnchor" id="H2969001259"><span class="h3">Irritation of eyes, nose, or throat</span><span class="headingEndMark"> — </span>Many of the same chemicals that cause dyspnea, cough, and wheezing also can irritate the eyes, nose, and throat. Routes of exposure include contact with vapor, splash injury, and ingestion. (See <a class="local">'Dyspnea, cough, or wheezing'</a> above.)</p><p>Chemicals with high water solubility preferentially cause upper respiratory tract (ie, nose and throat) irritation and injury and do not affect the lower respiratory tract unless exposure is massive or occurs in an enclosed space from which the patient cannot escape. </p><p>Exposure to ammonia, chlorine, hypochlorites, hydrochloric acid, hydrofluoric acid, sulfuric acid, hydroxides, formaldehyde, isocyanates, and chromium is discussed below. The general evaluation and management of occupational rhinitis (including irritant-induced rhinitis) are discussed separately. (See  <a class="medical medical_review" href="/d/html/7529.html" rel="external">"Occupational rhinitis"</a>.)</p><p class="headingAnchor" id="H3684920806"><span class="h3">Skin burn</span><span class="headingEndMark"> — </span>Occupational causes include splash injury with hydrochloric acid, hydrofluoric acid, sulfuric acid, hydroxides, ammonia, and other acids and bases. These are discussed below. (See <a class="local">'Selected caustics and irritants'</a> below.)</p><p>Signs and symptoms of common chemicals that cause burns are reviewed in the table  (<a class="graphic graphic_table graphicRef108485" href="/d/graphic/108485.html" rel="external">table 12</a>). The general evaluation and management of topical chemical burns are discussed separately. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a>.)</p><p class="headingAnchor" id="H1661188504"><span class="h3">Rash</span><span class="headingEndMark"> — </span>Rashes from occupational exposures generally include:</p><p class="bulletIndent1"><span class="glyph">●</span>Irritant contact dermatitis – This is the most common form of occupational contact dermatitis occurring in many high-risk occupations  (<a class="graphic graphic_table graphicRef56218" href="/d/graphic/56218.html" rel="external">table 13</a>). The general evaluation and management are discussed separately. (See  <a class="medical medical_review" href="/d/html/13661.html" rel="external">"Irritant contact dermatitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Allergic contact dermatitis – Many industrial chemicals are sensitizing agents that can cause allergic dermatitis. Common causes include hexavalent chromium; para-phenylenediamine (black dye); natural latex; and proteins present in various plants, animals, and food ingredients handled by workers. The general evaluation and management are discussed separately. (See  <a class="medical medical_review" href="/d/html/13655.html" rel="external">"Clinical features and diagnosis of allergic contact dermatitis"</a> and  <a class="medical medical_review" href="/d/html/13665.html" rel="external">"Management of allergic contact dermatitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Both allergic and irritant contact dermatitis – Wet cement is unique because it can cause both allergic and irritant contact dermatitis since it contains a sensitizing agent (hexavalent chromium) and has a caustic pH (10 to 12). (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Cement burns'</a>.) </p><p></p><p class="headingAnchor" id="H3977856391"><span class="h3">Signs of metabolic acidosis</span><span class="headingEndMark"> — </span>Occupational causes of an elevated anion-gap metabolic acidosis include carbon monoxide, cyanide, hydrogen sulfide, methylene chloride, and toxic alcohols. Lactate concentrations &gt;10 mmol/L are highly suggestive of poisoning with a cellular asphyxiant (eg, cyanide, hydrogen sulfide). (See  <a class="medical medical_review" href="/d/html/2291.html" rel="external">"Approach to the adult with metabolic acidosis", section on 'Diagnosis and evaluation'</a>.)</p><p class="headingAnchor" id="H3868082469"><span class="h1">EVALUATION AND MANAGEMENT BASED ON SELECTED, KNOWN EXPOSURES</span></p><p class="headingAnchor" id="H1556274284"><span class="h2">All caustics/irritants: general evaluation and management</span><span class="headingEndMark"> — </span>All caustics and irritants share similar initial evaluation and management, which are outlined below and discussed in detail separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Decontaminate dermal burns immediately with copious soap and water. Ocular exposure should be decontaminated with flushing of the eye with sterile water or normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> (ophthalmic anesthetic application may be helpful). (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Water irrigation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following decontamination, assess skin burn depth and evaluate ocular exposures for corneal burns and open globe injury. (See  <a class="medical medical_review" href="/d/html/6513.html" rel="external">"Open globe injuries: Emergency evaluation and initial management", section on 'Physical examination'</a> and  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Burn assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provide fluid resuscitation for large burns, similar to thermal burns. (See  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Fluid resuscitation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluate and manage respiratory tract signs and symptoms:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Suspect upper respiratory tract edema or injury based on clinical findings (eg, stridor, hoarseness) and confirm the diagnosis by visual inspection of the airway. (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Obtain a chest radiograph (CXR) in a patient with possible lower respiratory tract injury. Clinical manifestations include tachypnea, hypoxia, retractions, decreased breath sounds, wheezing, rales, rhonchi, and respiratory fatigue and failure. Some exposures (eg, chlorine, oxides of nitrogen) can cause delayed lung injury and require prolonged observation. (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants", section on 'Chest imaging'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Provide supportive treatment for upper and lower respiratory tract edema/injury. In a patient with stridor, administer nebulized racemic epinephrine (2.25% solution diluted in 2 to 3 mL normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>; 0.05 to 0.1 mL/kg; maximum dose 0.5 mL). Perform early tracheal intubation since airway injury or edema may progress. Treat bronchospasm with inhaled bronchodilators (eg, <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>). (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants", section on 'Pulmonary care'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe acute lung injury or acute respiratory distress syndrome (ARDS) may require mechanical ventilation. (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants", section on 'Ventilator management'</a> and  <a class="medical medical_review" href="/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not routinely decontaminate a caustic ingestion. Symptomatic patients should undergo endoscopy within 12 to 24 hours of the exposure for grading, and may need antibiotics or surgery. (See  <a class="medical medical_review" href="/d/html/2267.html" rel="external">"Caustic esophageal injury in adults"</a>.)</p><p></p><p class="headingAnchor" id="H3406394874"><span class="h2">Selected caustics and irritants</span></p><p class="headingAnchor" id="H1557503873"><span class="h3">Ammonia</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Aqueous ammonia (a dilute 5 to 10 percent solution of ammonia in water) is used for cleaning and disinfecting. Anhydrous ammonia is pure ammonia and is used in industrial refrigeration systems, in agriculture as a source of nitrogen, and in the illicit manufacture of methamphetamine in clandestine drug laboratories. </p><p></p><p class="bulletIndent1">Ammonia has a distinctive acrid odor detectable at low concentrations (5 parts-per-million [ppm]) that can alert workers of its presence. As such, most clinically significant occupational exposures to anhydrous ammonia occur when it is suddenly released into an enclosed space and the worker is unable to escape. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure </strong>[<a href="#rid4">4</a>] </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Topical aqueous ammonia: conjunctivitis and irritant dermatitis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ammonia vapor: conjunctivitis </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inhalation: upper respiratory tract irritation at low concentrations (50 to 100 ppm) and bronchospasm and pulmonary injury (ie, diffuse alveolar damage and/or ARDS) at higher concentrations (approximately 500 ppm)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anhydrous ammonia splash: freeze-dry burn similar to frostbite due to the cooling effect of rapid evaporation; clothing may be frozen to the skin</p><p></p><p class="bulletIndent1">Long-term sequelae can include reactive airways dysfunction syndrome (RADS) and reactive upper airways dysfunction syndrome (RUDS) [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a> and  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – Ophthalmic mast cell stabilizers (eg, <a class="drug drug_general" data-topicid="8798" href="/d/drug information/8798.html" rel="external">azelastine</a>, <a class="drug drug_general" data-topicid="16764" href="/d/drug information/16764.html" rel="external">ketotifen</a>) may be used for irritant conjunctivitis from aqueous ammonia. </p><p></p><p class="bulletIndent1">Frozen clothing from anhydrous ammonia should be removed only after flushing and warming to prevent inadvertent removal of adherent skin [<a href="#rid6">6,7</a>]. For anhydrous ammonia exposure, repeat irrigation should be performed every four to six hours for the first 24 hours. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Anhydrous ammonia'</a>.)</p><p></p><p class="bulletIndent1">The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="headingAnchor" id="H1621111383"><span class="h3">Hydrochloric acid</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Hydrochloric acid and muriatic acid (hydrochloric acid with impurities) are used in laboratories, cleaning or etching concrete, metal cleaning, jewelry manufacture and cleaning, removal of scale from toilets and swimming pools, and in the illicit production of methamphetamine. </p><p></p><p class="bulletIndent1">Muriatic acid is faintly yellow with a sharp, pungent odor that limits inhalational exposure. Muriatic acid fumes are denser than air and may accumulate in low-lying areas. These are strong acids with a pH of 1 to 2. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Exposure immediately causes tissue injury (coagulative necrosis) with eschar formation that limits the depth of injury [<a href="#rid8">8</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dermal or ophthalmic: chemical burns </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute inhalational: predominantly upper airway injury with burning pain, tissue edema, cough, laryngospasm, and asphyxia; more intense exposures may result in lower airway injury with pulmonary edema, bronchospasm, and ARDS </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic low-level inhalational/vapor: chronic respiratory tract irritation, nasal septal ulceration or perforation, conjunctivitis, and dental enamel erosion and discoloration [<a href="#rid9">9</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="headingAnchor" id="H4181597940"><span class="h3">Chlorines/hypochlorites</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Chlorine is a green-yellow gas with intermediate water solubility. Chlorine gas has an irritating, pungent odor ("odor of bleach"). It reacts with water to form toxic products: hydrochloric acid (a caustic) and hypochlorous acid (forms free radicals). </p><p></p><p class="bulletIndent1">Individuals maintaining swimming pools can be exposed to chlorine gas if chlorine tablets are handled improperly. Aqueous chlorine gas is used for pool chlorination by commercial services. Individuals using cleaning agents can be exposed when chlorine gas is generated from mixing chlorine acids with bases (eg, muriatic acid mixed with bleach). Firefighters may be exposed to chlorine gas generated during the combustion of chlorinated hydrocarbons (eg, polyvinyl chloride). </p><p></p><p class="bulletIndent1">Hypochlorites are used as cleaning or disinfecting agents. Household bleach is sodium hypochlorite. </p><p></p><p class="bulletIndent1">Chloramine gas forms when hypochlorites are mixed with a nitrogen donor such as ammonia. Chloramine gas has high water solubility and is a potent respiratory irritant, which typically forces the individual to leave the hazardous environment. Chloramine gas is also a sensitizer. Lifeguards at commercial pools may experience chronic low-dose chloramine exposure from pool chlorine mixing with human nitrogenous wastes [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Chlorine gas exposure can affect both the upper and lower respiratory tracts. Hydrochloric and hypochlorous acid are produced in the lower respiratory tract, causing a potentially slow-onset caustic injury.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute chlorine gas inhalation: mucous membrane irritation/injury and parenchymal injury; airway compromise, pulmonary edema, and ARDS can develop and may be delayed up to six hours after exposure [<a href="#rid11">11</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Low-intensity repeated chlorine gas: may cause chronic respiratory complaints and flu-like symptoms; long term sequelae can include RADS and RUDS (see  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dermal hypochlorite: allergic and irritant contact dermatitis [<a href="#rid12">12</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ophthalmic liquid or aerosolized hypochlorite: irritant conjunctivitis and chemosis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ingestion of industrial-strength hypochlorite solution: esophageal and stomach injury and perforation; such injury is rare with accidental ingestion of household (approximately 5 percent) bleach (see  <a class="medical medical_review" href="/d/html/2267.html" rel="external">"Caustic esophageal injury in adults"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute chloramine gas: rapid-onset nasopharyngeal irritation; pulmonary edema and ARDS if exposure to high concentration or in enclosed spaces [<a href="#rid13">13</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic low-level chloramine gas: occupational asthma (see  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a> and  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – In a patient with an inhalational exposure, we monitor for at least six hours with serial pulmonary examinations and pulse oximetry because of concern for delayed-onset lung injury. The CXR on presentation may be normal in a patient with a potentially toxic exposure. We obtain a CXR in any patient with hypoxia or signs of lung injury (eg, tachypnea, abnormal lung auscultation). We also obtain a CXR in a patient with mild to moderate symptoms (eg, cough, mucous membrane irritation) that have not improved after six hours. A patient who is asymptomatic (or minimally symptomatic and improving) with normal vital signs after six hours can be discharged. Any patient with hypoxia or infiltrates on CXR should be admitted for monitoring for respiratory decompensation. </p><p></p><p class="bulletIndent1">Management of inhalational exposure is mostly supportive. We provide humidified supplemental oxygen for hypoxia, dyspnea, and/or upper airway irritation and inhaled beta-adrenergic agonists (eg, <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>) for bronchospasm and/or cough [<a href="#rid14">14,15</a>]. We administer nebulized <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> solution (eg, 4 mL of 3.75% solution) to help control symptoms such as chest pain and throat irritation. However, evidence is mostly observational and/or does not routinely demonstrate a benefit [<a href="#rid16">16-21</a>]. A patient with severe lung injury may require mechanical ventilation. (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants", section on 'Ventilator management'</a> and  <a class="medical medical_review" href="/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department"</a>.)</p><p></p><p class="bulletIndent1">In a patient with a severe inhalational injury (eg, bilateral pulmonary infiltrates, respiratory failure), we suggest administering a glucocorticoid. A reasonable approach is to administer similar doses used to treat a severe asthma exacerbation (eg, <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a> 60 to 80 mg every 6 to 12 hours), but a routinely accepted protocol does not exist. Some experts may administer inhaled glucocorticoids (eg, <a class="drug drug_general" data-topicid="9167" href="/d/drug information/9167.html" rel="external">budesonide</a>) in addition or as an alternative. The evidence for benefit is not conclusive and mostly based on animal models and observational studies [<a href="#rid22">22-29</a>]. Glucocorticoids may inhibit neutrophilic response and release of inflammatory mediators that cause mismatch of ventilation and perfusion, thus limiting progression of lung injury.</p><p></p><p class="bulletIndent1">The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.) </p><p></p><p class="headingAnchor" id="H1326775386"><span class="h3">Phosgene</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Phosgene has been used as a chemical warfare agent and in various industrial processes, including the polyurethane industry, chemical (eg, dye, pesticide, pharmaceutical) manufacturing, ore processing, and welding [<a href="#rid30">30</a>]. Phosgene is a liquid at cold temperatures (&lt;0°C [32°F]) and is otherwise a colorless gas or white cloud that is heavier than air. The gas is described to have an odor of newly mown or musty hay, grass, or corn. The odor threshold is between 0.5 and 1.5 ppm [<a href="#rid31">31</a>]. Its use in chemical warfare is discussed separately. (See  <a class="medical medical_review" href="/d/html/2020.html" rel="external">"Chemical terrorism: Rapid recognition and initial medical management"</a>.)</p><p></p><p class="bulletIndent1">Phosgene (COCl<sub>2</sub>) has low water solubility. It minimally reacts with water in the upper respiratory tract but hydrolyzes to hydrochloric acid (caustic) and carbon dioxide in the lower airways [<a href="#rid31">31</a>]. It also reacts with functional groups (eg, amino, hydrazino, sulfhydryl), causing protein acylation, lipid and protein denaturation, membrane damage, and disruption of enzymes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Exposure to phosgene gas can cause mucous membrane irritation, choking-like sensation, cough, vomiting, and delayed-onset pulmonary edema or ARDS [<a href="#rid31">31,32</a>]. Significant mucous membrane irritation may not occur resulting in prolonged exposure. Moderate concentration exposure characteristically produces a symptom-free latent period of 2 to 24 hours, followed by chest pain and progressive dyspnea that can worsen in severity over two to three days. High-concentration exposure can produce a shorter latent period. Hypotension has been reported in patients who develop ARDS [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1">Following a phosgene exposure, most patients fully recover within one to three weeks, but reported long-term sequelae include chronic bronchitis, emphysema, and RADS [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p></p><p class="bulletIndent1">Contact with the liquid form can cause erythema, severe burns (ie, frostbite), or conjunctivitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – In a patient with an inhalational exposure, we monitor for at least 24 hours with serial pulmonary examinations and pulse oximetry because of concern for delayed-onset lung injury. The CXR may shows pulmonary edema; early findings (four to eight hours after exposure) can include hilar enlargement or ill-defined patchy infiltrates that can ultimately progress to ARDS [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1">Management of inhalational exposure is mostly supportive and similar to chlorine gas (discussed immediately above). Vasopressors may be needed for hypotension that does not improve with intravenous crystalloid. Use of intravenous glucocorticoids and nebulized <a class="drug drug_general" data-topicid="9317" href="/d/drug information/9317.html" rel="external">N-acetylcysteine</a> has been described, but evidence is limited to small observational studies [<a href="#rid32">32</a>]. A patient with severe lung injury may require mechanical ventilation. (See  <a class="medical medical_review" href="/d/html/105477.html" rel="external">"Inhalation injury from heat, smoke, or chemical irritants", section on 'Ventilator management'</a> and  <a class="medical medical_review" href="/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department"</a>.)</p><p></p><p class="bulletIndent1">The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="headingAnchor" id="H3092193086"><span class="h3">Sulfurous/sulfuric acid</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Sulfuric acid is used in the production of lead-acid (eg, automobile, boat) batteries, cleaning products (eg, drain cleaner), wastewater treatment, textile manufacturing, chemical manufacturing, jewelry manufacturing, agriculture, fertilizer production (ammonium sulfate), clandestine drug manufacture, and mineral extraction. Sulfur dioxide is used in smelting and oil refinery industries and is converted to sulfurous acid (H<sub>2</sub>SO<sub>3</sub>) when dissolved in water.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Caustic injury causes coagulative necrosis with eschar formation, which limits the depth of tissue injury. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gastrointestinal, dermal, or ophthalmic: chemical burns</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dilute sulfuric acid: irritant contact dermatitis that may manifest after exposure cessation </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sulfuric acid mist or vapor: highly irritating to the upper and lower respiratory tracts with upper airway burning pain, cough, or dyspnea and laryngeal edema and ARDS if intense exposure; long-term sequelae include RADS [<a href="#rid33">33,34</a>] (see  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – Laboratory testing, although not required, may demonstrate an elevated anion gap due to the unmeasured bisulfate ion. (See  <a class="medical medical_review" href="/d/html/2347.html" rel="external">"Serum anion gap in conditions other than metabolic acidosis"</a>.)</p><p></p><p class="bulletIndent1">The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="headingAnchor" id="H101309097"><span class="h3">Formaldehyde</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Formaldehyde is a small organic compound commonly stored as formalin, a saturated aqueous solution (approximately 40 percent formaldehyde) that typically also contains methanol as a stabilizing agent. It is used as a fumigant, disinfectant, histologic fixative, embalming agent, precursor chemical; in textile production, fertilizer production, paper production, foundry work; as a binding agent for particle board and plywood; and in the production of resins. It is also a thermal decomposition product and may be present in smoke.</p><p></p><p class="bulletIndent1">Formaldehyde is a gas under ambient conditions with a strong, pungent odor. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute formaldehyde inhalation/vapor: eye and nasopharyngeal irritation (potentially severe); bronchospasm, pulmonary edema, and ARDS with higher concentration exposure</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Splash ophthalmic exposure: corneal opacity formation [<a href="#rid35">35</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dermal: irritant contact dermatitis; workers with repeated exposure may develop an allergic contact dermatitis [<a href="#rid36">36</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Formalin ingestion: even small amounts can cause gastrointestinal injury, metabolic acidosis, and may be fatal [<a href="#rid37">37</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic formaldehyde exposure: known human carcinogen [<a href="#rid38">38</a>]; associated with reversible decrements in pulmonary function testing</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – A patient with dermatitis from minimal or only airborne exposure should be referred for allergy patch testing to determine if they are sensitized to formaldehyde. (See  <a class="medical medical_review" href="/d/html/13655.html" rel="external">"Clinical features and diagnosis of allergic contact dermatitis"</a>.)</p><p></p><p class="bulletIndent1">In a patient with formalin ingestion and metabolic acidosis, we recommend intravenous <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> and hemodialysis. Sodium bicarbonate administration attenuates the severe metabolic acidosis from formaldehyde metabolism to formic acid, may improve the effectiveness of vasopressors, and may increase renal excretion of formate. Hemodialysis can correct a metabolic acidosis and effectively eliminate formaldehyde, formic acid, and methanol [<a href="#rid37">37,39,40</a>]. (See  <a class="medical medical_review" href="/d/html/2291.html" rel="external">"Approach to the adult with metabolic acidosis", section on 'Acute metabolic acidosis'</a> and  <a class="medical medical_review" href="/d/html/126052.html" rel="external">"Methanol and ethylene glycol poisoning: Management"</a>.)</p><p></p><p class="bulletIndent1">The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="headingAnchor" id="H2872630315"><span class="h3">Hydroxides</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Hydroxides (eg, sodium hydroxide, potassium hydroxide, calcium hydroxide, others) are found in cleaning products (eg, drain and oven cleaner, degreasers), cement/mortar, mining applications, paint removers, cosmetics, clandestine drug manufacturing, semiconductor manufacturing, pulp and paper manufacturing, roadbuilding, and jewelry manufacturing. They are strong bases and used for pH adjustment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Hydroxides cause liquefactive necrosis and saponify cell membranes and fats, resulting in deeper tissue injury compared with acids. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dermal or ophthalmic: chemical burns; dilute (&lt;2 percent) liquid hydroxides or hydroxide dust can causes irritant contact dermatitis [<a href="#rid41">41</a>] (see  <a class="medical medical_review" href="/d/html/13661.html" rel="external">"Irritant contact dermatitis in adults"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inhalation of hydroxide aerosols or cement dust: upper airway injury with burning pain, edema, and cough; more intense exposures may cause lower respiratory tract injury and ARDS [<a href="#rid42">42</a>] </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ingestion: esophageal and/or gastric perforation and mediastinitis; concentrated hydroxide (eg, lye) ingestion poses high risk of transmural necrosis and perforation (see  <a class="medical medical_review" href="/d/html/2267.html" rel="external">"Caustic esophageal injury in adults"</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="headingAnchor" id="H41110634"><span class="h3">Isocyanates</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Isocyanates are used in the manufacture of polyurethane products such as paints, surface coatings, furniture, foams, insulation materials, and adhesives. Exposures can occur during polyurethane product manufacturing or during the application of polyurethane paint, surface coatings, or spraying of polyurethane foams. Pyrolysis and thermal decomposition of polyurethane products may release isocyanates. </p><p></p><p class="bulletIndent1">Isocyanates are water soluble, highly reactive, low molecular weight chemicals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Isocyanates cause upper airway mucous membrane irritation, conjunctivitis, cough, and shortness of breath. High-concentration exposures can cause pulmonary edema, hypersensitivity pneumonitis ("bathtub refinisher's lung"), RADS, bronchiolitis obliterans, and hypoxic respiratory failure [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a> and  <a class="medical medical_review" href="/d/html/4323.html" rel="external">"Overview of bronchiolar disorders in adults", section on 'Bronchiolitis obliterans'</a>.)</p><p></p><p class="bulletIndent1">Diisocyanates (eg, toluene diisocyanate) are potent sensitizing agents and one of the most common causes of occupational asthma, which occurs in 5 to 15 percent of exposed workers [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – The general evaluation and management are described above. (See <a class="local">'All caustics/irritants: general evaluation and management'</a> above.)</p><p></p><p class="bulletIndent1">Sensitization to isocyanates mandates removal from exposure. Even a low-level exposure can precipitate life-threatening bronchospasm in a sensitized individual [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/d/html/15718.html" rel="external">"Occupational asthma: Management, prognosis, and prevention"</a>.)</p><p></p><p class="headingAnchor" id="H976033236"><span class="h3">Hydrofluoric acid</span><span class="headingEndMark"> — </span>Hydrofluoric acid is used as a rust remover; wheel or car wash cleaner; cleaning agent for metal, brick, and stone; glass and silicon etching (eg, in semiconductor wafer manufacture); and in petrochemical refining. Concentrated hydrofluoric acid solutions cause immediate caustic injury, whereas dilute solutions cause delayed toxicity from local or systemic hypocalcemia. Inhalational, ocular, oral, or dermal exposures, as well as systemic toxicity from hypocalcemia and hyperkalemia, can occur. Chronic inhalational exposure may result in sensitization and occupational asthma ("potroom worker's asthma"). The evaluation and management of hydrofluoric acid exposure are discussed separately. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Hydrofluoric (HF) acid'</a>.)</p><p class="headingAnchor" id="H891149424"><span class="h2">Cellular asphyxiants</span></p><p class="headingAnchor" id="H394318957"><span class="h3">Hydrogen sulfide</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Hydrogen sulfide is a byproduct of microbial decomposition of organic matter (eg, rotting fish in the hull of boat) and various industrial processes in oil, coal, and natural gas extraction and refining, sewage treatment, paper mills, leather manufacturing, roofing asphalt, construction, agriculture (eg, manure pits), and clandestine drug manufacturing.</p><p></p><p class="bulletIndent1">Hydrogen sulfide is a colorless gas that is heavier than air. It has a "rotten egg" odor that may alert workers, but the odor is not universally protective since paralysis of the olfactory nerve occurs with exposures &gt;100 ppm [<a href="#rid46">46</a>]. Hydrogen sulfide poses significant risk to rescuers with inadequate or without personal protective equipment (PPE). In a study of fatal occupational hydrogen sulfide poisonings, 21 percent of incidents also resulted in the death of a coworker or rescuer [<a href="#rid47">47</a>]. </p><p></p><p class="bulletIndent1">Hydrogen sulfide is a potent inhibitor of mitochondrial cytochrome oxidase and interferes with oxidative phosphorylation. It reacts with water to form sodium sulfide, which is a local irritant. It reacts with copper and silver producing a black tarnish on coins and jewelry.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ophthalmic: keratitis, photophobia, and blepharospasm at low hydrogen sulfide concentrations (50 ppm); corneal ulceration at higher concentrations</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pulmonary: dyspnea and cough that can progress to hemorrhagic pulmonary edema and ARDS; the onset of pulmonary edema may be immediate or delayed (in patients surviving immediate poisoning) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Systemic/metabolic: confusion, headache, dizziness, seizure, sudden loss of consciousness ("knockdown agents"), severe elevated anion-gap metabolic acidosis (blood pH &lt;7.0, lactate concentrations &gt;10 mmol/L), and cardiovascular collapse at concentrations &gt;250 ppm</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Low-dose chronic exposure: mucous membrane irritation, eye irritation, fatigue, headache, dizziness, and memory impairment</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – Hydrogen sulfide poisoning is a clinical diagnosis and is suspected in patients with an occupational exposure who rapidly develop severe lactic acidosis, altered mental status, and cardiovascular collapse. The presence of a black tarnish on coins or jewelry is a clue. Testing includes serum chemistries, lactate, complete blood count, arterial blood gas, electrocardiogram, and CXR.</p><p></p><p class="bulletIndent1">The only necessary decontamination is removal of clothing. Initial care is supportive. Patients are often critically ill and require tracheal intubation and circulatory support (eg, intravenous fluids, vasopressors). A patient with clinically significant poisoning (symptoms other than just local irritation) should receive high-flow oxygen (eg, nonrebreather mask, high-flow nasal cannula). A patient with lactic acidosis and severe acidemia (pH less than 7.1) should be treated with <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> infusion. (See  <a class="medical medical_review" href="/d/html/2294.html" rel="external">"Bicarbonate therapy in lactic acidosis", section on 'Approach'</a>.)</p><p></p><p class="bulletIndent1">In a patient with neurologic or cardiovascular toxicity that does not improve quickly (within one to two hours), we suggest <a class="drug drug_general" data-topicid="85782" href="/d/drug information/85782.html" rel="external">sodium nitrite</a> 300 mg intravenously and hyperbaric oxygen (if available and the patient is stable for transfer to a chamber). Sodium nitrite may help reestablish aerobic metabolism by facilitating binding of hydrogen sulfide to ferric iron in methemoglobin, but evidence is limited to case reports [<a href="#rid48">48,49</a>]. Hyperbaric oxygen may increase the availability of oxygen to competitively inhibit sulfide-cytochrome binding, enhance detoxification of hydrogen sulfide, and minimize tissue injury, but evidence is also limited to case reports [<a href="#rid50">50,51</a>]. (See  <a class="medical medical_review" href="/d/html/326.html" rel="external">"Hyperbaric oxygen therapy"</a>.) </p><p></p><p class="headingAnchor" id="H2035611888"><span class="h3">Carbon monoxide</span><span class="headingEndMark"> — </span>Carbon monoxide poisoning, a common cause of occupational injury and death, is frequently associated with the operation of internal combustion engines (eg, generators, forklifts) in enclosed spaces. Occupational exposure can also occur from inhalation or ingestion of methylene chloride (dichloromethane), a solvent used in industrial processes, adhesives, paints, stains, chemical processing, and metal cleaning, which is hepatically metabolized to carbon monoxide. The evaluation and management of carbon monoxide poisoning are discussed separately. (See  <a class="medical medical_review" href="/d/html/322.html" rel="external">"Carbon monoxide poisoning"</a>.)</p><p class="headingAnchor" id="H2945171174"><span class="h2">Hydrocarbons</span></p><p class="headingAnchor" id="H4254980894"><span class="h3">N-hexane, methyl-n-butyl ketone</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – N-hexane and methyl-N-butyl ketone are used as solvents, most commonly for adhesives. Inhalational exposures can occur in industries such as textile manufacturing, furniture manufacture, shoemaking, roofing, printing facilities, and laminating. Both are metabolized to 2,5-hexanedione, which causes an axonal polyneuropathy ("shoemakers' polyneuropathy") [<a href="#rid52">52</a>]. The neuropathy can also occur with recreational misuse of solvents (eg, glue sniffing). (See  <a class="medical medical_review" href="/d/html/5284.html" rel="external">"Overview of polyneuropathy"</a> and  <a class="medical medical_review" href="/d/html/6166.html" rel="external">"Overview of acquired peripheral neuropathies in children", section on 'Toxins'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Manifestations of the polyneuropathy include distal numbness, tingling, sensory loss, and symmetric, ascending weakness. The distal axonal degeneration produces a dying-back neuropathy affecting both motor and sensory nerves. Upper motor neuron damage has also been reported, resulting in spasticity and increased deep tendon reflexes [<a href="#rid53">53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – Nerve conduction studies may demonstrate slowing of both motor and sensory conduction velocities. (See  <a class="medical medical_review" href="/d/html/5142.html" rel="external">"Overview of nerve conduction studies"</a>.)</p><p></p><p class="bulletIndent1">Management is cessation of exposure. Recovery is slow and may be incomplete.</p><p></p><p class="headingAnchor" id="H2072614425"><span class="h3">Toluene</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses and chemical properties</strong> – Toluene is an aromatic hydrocarbon used as an organic solvent for spray paint, stains, oil paints, inks, paint thinners, leather tanning, degreasing agents, nail polish, and in numerous other industrial and commercial products.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong> – Acute exposure mimics alcohol intoxication (eg, sedation, ataxia, confusion) and can sensitize the myocardium to catecholamine-induced dysrhythmias. </p><p></p><p class="bulletIndent1">Chronic toluene exposure is associated with prolonged or permanent neuropsychiatric sequelae ("painter's syndrome") that include deficits in memory, attention, executive function, and processing speed. Physical examination findings can include dysarthria, increased deep tendon reflexes, ataxia, and impaired vision and hearing. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – The evaluation and management of acute aromatic hydrocarbon exposure are discussed separately. (See  <a class="medical medical_review" href="/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">In a patient with chronic toluene exposure, magnetic resonance imaging may demonstrate white matter degeneration (ie, leukoencephalopathy) with cortical and cerebellar atrophy [<a href="#rid54">54</a>]. Electroencephalography may demonstrate diffuse slowing [<a href="#rid55">55</a>]. A postshift urine hippuric acid, <em>o</em>-cresol, or benzylmercapturic acid concentration can be obtained as a marker of exposure [<a href="#rid56">56,57</a>]. (See  <a class="medical medical_review" href="/d/html/6502.html" rel="external">"Inhalant misuse in children and adolescents", section on 'Hydrocarbons'</a>.)</p><p></p><p class="headingAnchor" id="H2421356874"><span class="h3">Methane, propane, butane</span><span class="headingEndMark"> — </span>Propane and butane are components of liquefied petroleum gas (LPG, or autogas). Methane is the main component of compressed natural gas (CNG). Exposures can occur from working with equipment that uses LPG/CNG as fuel (eg, trash trucks, ice resurfacers, forklifts, generators) or in the LPG/CNG storage and transportation industry. A leak in an enclosed area from an LPG/CNG tank, storage, or transportation container can result in accumulation of methane, propane, and butane gas and cause asphyxiation by displacing oxygen from the air. Both propane and butane are used in torches, as fuels, and as propellants for aerosols in various applications such as oil-based cooking sprays, insecticide-fogging mixtures, and cosmetic/personal care aerosols. The evaluation and management of acute aliphatic hydrocarbon exposure are discussed separately. (See  <a class="medical medical_review" href="/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis"</a>.) </p><p>Chronic exposure to LPG/CNG has been associated with respiratory complaints and decreased pulmonary function indices on spirometry, likely from nitrogen dioxide in the combustion products [<a href="#rid58">58</a>]. (See  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p class="headingAnchor" id="H2201270521"><span class="h2">Metals</span></p><p class="headingAnchor" id="H2347974902"><span class="h3">Chromium</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational uses</strong> – Chromium is used for pigment production, leather tanning, electroplating, as a wood preservative, as an anti-corrosive agent, and in galvanizing solutions. Cement workers and leather tanners are at high risk for sensitization [<a href="#rid59">59</a>]. Exposure is typically dermal.</p><p></p><p class="bulletIndent1">Inhalational exposure can occur if chromium fumes are liberated during welding of stainless steel.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations of exposure</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dermal: inflammation (hand dermatitis, "blackjack disease") and ulceration ("chrome holes"); sensitization to chromium causes allergic contact dermatitis (see  <a class="medical medical_review" href="/d/html/13655.html" rel="external">"Clinical features and diagnosis of allergic contact dermatitis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute inhalation: respiratory tract irritation, cough, and shortness of breath</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Repeated inhalational exposures: respiratory tract ulcerations, including nasal septal perforation; pulmonary sensitization may occur, causing bronchospasm and occupational asthma (see  <a class="medical medical_review" href="/d/html/536.html" rel="external">"Irritant-induced asthma"</a> and  <a class="medical medical_review" href="/d/html/537.html" rel="external">"Occupational asthma: Definitions, epidemiology, causes, and risk factors"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Management includes dermal decontamination and removal from exposure, which may necessitate job change. Management of allergic contact dermatitis and occupational asthma is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/13665.html" rel="external">"Management of allergic contact dermatitis in adults"</a> and  <a class="medical medical_review" href="/d/html/15718.html" rel="external">"Occupational asthma: Management, prognosis, and prevention"</a>.)</p><p></p><p class="headingAnchor" id="H3912867791"><span class="h3">Zinc oxide fumes</span><span class="headingEndMark"> — </span>Inhalation of <a class="drug drug_general" data-topicid="10326" href="/d/drug information/10326.html" rel="external">zinc oxide</a> fumes, which typically occurs in welders, can cause "metal fume fever" (also called "Monday morning syndrome," "foundry fever," "smelter shakes," and "welder's ague") [<a href="#rid60">60,61</a>]. Inhalation of other metal oxides, such as copper, magnesium, tin, or cadmium, may also be contributory or causative. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Symptoms of metal fume fever include cough, dyspnea, chest tightness, fevers, chills, malaise, headaches, and myalgias. Symptoms start abruptly four to eight hours after fume exposure and resolve spontaneously within 24 to 48 hours. Short-term tolerance (ie, tachyphylaxis) develops and repeated exposure towards the end of the workweek does not cause symptoms, but symptoms recur on Monday following absence of exposure during the weekend. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – CXR is typically normal, but may demonstrate diffuse patchy infiltrates in severe cases. Treatment is supportive; supplemental oxygen or bronchodilators are rarely needed. Patients require a careful workplace exposure assessment and adherence to using PPE while welding.</p><p></p><p class="headingAnchor" id="H3436765661"><span class="h3">Lead</span><span class="headingEndMark"> — </span>Occupations associated with lead exposure include firing range workers, commercial painters (eg, bridges), welders, crystal glass makers, lead-storage battery manufacturing, lead smelters, and renovators of older residential buildings (lead was banned from residential paint in 1978 in the United States). Lead exposure is typically chronic and occurs from inhalation of lead dust or fumes. Manifestations range in severity and can include somnolence, anhedonia, hypertension, headaches, memory loss, kidney injury, anemia, peripheral neuropathy, encephalopathy, and seizures. The evaluation and management of lead poisoning are discussed separately. (See  <a class="medical medical_review" href="/d/html/2773.html" rel="external">"Lead exposure, toxicity, and poisoning in adults"</a>.)</p><p class="headingAnchor" id="H2431389304"><span class="h3">Cadmium</span><span class="headingEndMark"> — </span>Cadmium is used as an anticorrosive metal surface coating in welding. Acute exposure to cadmium oxide fumes causes a severe pneumonitis. Chronic exposure is associated with kidney interstitial injury, osteomalacia, pathologic fractures, obstructive lung disease, and lung cancer. The evaluation and management of cadmium toxicity are discussed separately. (See  <a class="medical medical_review" href="/d/html/7202.html" rel="external">"Epidemiology and toxicity of cadmium"</a>.)</p><p class="headingAnchor" id="H3137676745"><span class="h1">FOLLOW-UP CARE</span><span class="headingEndMark"> — </span>Patients with injury or disease caused by an occupational exposure should be instructed to arrange follow-up with an occupational health specialist. In many cases, occupational exposures, injury, or disease are considered reportable to the Occupational Safety and Health Administration (OSHA) and should be reported by the employer. (See <a class="local">'Occupational/environmental medicine clinicians'</a> below and  <a class="medical medical_review" href="/d/html/2749.html" rel="external">"Overview of occupational and environmental health", section on 'Follow-up'</a>.) </p><p class="headingAnchor" id="H3254846687"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H204761013"><span class="h2">Regional poison centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H3410953483"><span class="h2">Occupational/environmental medicine clinicians</span><span class="headingEndMark"> — </span>Clinicians specializing in Occupational and Environmental Medicine can be located by contacting the Association of Occupational and Environmental Clinics (AOEC), a group of occupational medicine clinics (frequently academically affiliated) with board-certified occupational medicine physicians (phone: 202-347-4976; website: <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.aoec.org%2F&amp;token=ZG1%2BPwRUU1rBex5m1Ml5lfAIA%2B4JXtDbEUxLiSfLiuI%3D&amp;TOPIC_ID=141272" target="_blank">www.aoec.org</a>), or the American College of Occupational and Environmental Medicine Physicians (<a class="external" href="/external-redirect?target_url=http%3A%2F%2Facoem.org%2Ffind-a-provider&amp;token=2LZ3sEteCO1fR53xlXIWCAFcdzNfUkgiDwD4hRJz%2BMtta2P5qMpSBC8jS74UTYZ9&amp;TOPIC_ID=141272" target="_blank">www.acoem.org</a>).</p><p class="headingAnchor" id="H3111078639"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112689.html" rel="external">"Society guideline links: General measures for acute poisoning treatment"</a> and  <a class="medical medical_society_guidelines" href="/d/html/114014.html" rel="external">"Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse"</a> and  <a class="medical medical_society_guidelines" href="/d/html/112690.html" rel="external">"Society guideline links: Lead and other heavy metal poisoning"</a>.)</p><p class="headingAnchor" id="H962306214"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial evaluation and management</strong> – Patients may seek care knowing to which substance they were exposed, or the clinician may have to deduce the possible exposure based on job description, workplace environment, and clinical manifestations. The most common substances associated with fatal occupational poisoning in the United States include hydrogen sulfide, ammonia, carbon monoxide, simple asphyxiants, and chlorines. The product's (if known) Safety Data Sheet (SDS) may provide information on the component substances, pH, expected toxicity, and management. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Initial evaluation and management'</a> above.)</p><p></p><p class="bulletIndent1">Decontamination typically occurs after airway, breathing, and circulation (ABCs) are assessed, but may need to be performed during the initial resuscitation in the critically ill patient. Some exposures require specific decontamination  (<a class="graphic graphic_table graphicRef70216" href="/d/graphic/70216.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef97349" href="/d/graphic/97349.html" rel="external">table 3</a>). (See <a class="local">'Assess and stabilize ABCs'</a> above and <a class="local">'Decontamination'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis if exposure is unknown</strong> – Identifying a toxidrome  (<a class="graphic graphic_table graphicRef71268" href="/d/graphic/71268.html" rel="external">table 4</a>); characteristic odor  (<a class="graphic graphic_table graphicRef76045" href="/d/graphic/76045.html" rel="external">table 5</a>); or disturbances in temperature  (<a class="graphic graphic_table graphicRef55439" href="/d/graphic/55439.html" rel="external">table 6</a>), heart rate and blood pressure  (<a class="graphic graphic_table graphicRef51200" href="/d/graphic/51200.html" rel="external">table 7</a>), and respiration  (<a class="graphic graphic_table graphicRef64012" href="/d/graphic/64012.html" rel="external">table 8</a>) can suggest a toxin class and guide initial management. Most occupational exposures produce immediate symptoms but notable exceptions include low water solubility agents (eg, chlorine, oxides of nitrogen, phosgene), ethylene glycol, methanol, methylene chloride, and hydrofluoric acid. The presence and onset of clinical manifestations can also provide clues to the nature and extent, such as the following (see <a class="local">'General approach'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Altered mental status</strong> – Carbon monoxide, cyanide, hydrogen sulfide, hydrocarbons (eg, toluene, xylene), toxic alcohols, methylene chloride, arsenic, simple asphyxiants, and nonoccupational etiologies (see <a class="local">'Altered mental status'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dyspnea, cough, or wheezing</strong> – Caustics/irritants (eg, hydrofluoric acid, hydrochloric acid, chlorine, hypochlorites, sodium hydroxide, chloramine, oxides of nitrogen), sensitizers (eg, diisocyanates, chloramine)  (<a class="graphic graphic_table graphicRef66185" href="/d/graphic/66185.html" rel="external">table 10</a>), agents that cause hypersensitivity pneumonitis  (<a class="graphic graphic_table graphicRef68812" href="/d/graphic/68812.html" rel="external">table 11</a>), <a class="drug drug_general" data-topicid="10326" href="/d/drug information/10326.html" rel="external">zinc oxide</a> fumes, and pneumoconioses (see <a class="local">'Dyspnea, cough, or wheezing'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Irritation of eyes, nose, or throat </strong>– Typically agents with high water solubility (eg, ammonia, chlorine, hypochlorites, hydrochloric acid, hydrofluoric acid, sulfuric acid, hydroxides, formaldehyde, isocyanates, chromium, many others) (see <a class="local">'Irritation of eyes, nose, or throat'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Skin burns and rashes</strong> – Includes acids/bases (eg, hydrochloric acid, hydrofluoric acid, sodium hydroxide, ammonia), irritants  (<a class="graphic graphic_table graphicRef56218" href="/d/graphic/56218.html" rel="external">table 13</a>), and sensitizers (see <a class="local">'Skin burn'</a> above and <a class="local">'Rash'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Signs of metabolic acidosis</strong> – Carbon monoxide, cyanide, hydrogen sulfide, methylene chloride, and toxic alcohols (see <a class="local">'Signs of metabolic acidosis'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management based on known exposure</strong> – Common occupational exposures are presented above and some selected exposures are summarized below (see <a class="local">'Evaluation and management based on selected, known exposures'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chlorine</strong> – Chlorine gas has an irritating, pungent odor (the "odor of bleach") and can injure both the upper and lower respiratory tracts. Signs of lung injury may be delayed up to six hours after exposure. Patients should be monitored for at least six hours with serial pulmonary examination and pulse oximetry for delayed-onset respiratory symptoms. Symptomatic patients are managed with respiratory support, humidified supplemental oxygen, and inhaled beta-adrenergic agonists (eg, <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>). Nebulized <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> solution (eg, 4 mL of 3.75% solution) may help control symptoms such as chest pain and throat irritation but likely does not provide a therapeutic benefit. In a patient with a severe inhalational injury (eg, bilateral pulmonary infiltrates, respiratory failure), we suggest administering glucocorticoids (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). A reasonable dose is <a class="drug drug_general" data-topicid="9639" href="/d/drug information/9639.html" rel="external">methylprednisolone</a> 60 to 80 mg every 6 to 12 hours. These may limit progression of lung injury by inhibiting neutrophilic response and release of inflammatory mediators. (See <a class="local">'Chlorines/hypochlorites'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Formaldehyde/formalin</strong> – Exposure can cause ocular, skin, and upper and lower respiratory tract irritation. Splash exposure can cause corneal opacity formation. Formalin ingestions can cause gastrointestinal injury, metabolic acidosis, and may be fatal. These require upper endoscopy. In a patient with formalin ingestion and metabolic acidosis, we recommend intravenous <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> and hemodialysis (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Sodium bicarbonate may temporize the acidosis and hemodialysis can effectively eliminate formaldehyde, formic acid, and methanol. (See <a class="local">'Formaldehyde'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hydrogen sulfide</strong> – Manifestations include ocular irritation, pulmonary edema, sudden loss of consciousness, cardiovascular collapse, and severe lactic acidosis. Initial management is supportive with high-flow supplemental oxygen, circulatory support, and <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> infusion (if acidosis present). In a patient with neurologic or cardiovascular toxicity that does not improve quickly (within one to two hours), we suggest <a class="drug drug_general" data-topicid="85782" href="/d/drug information/85782.html" rel="external">sodium nitrite</a> and hyperbaric oxygen (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). The dose of sodium nitrite is 300 mg intravenously. (See <a class="local">'Hydrogen sulfide'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gummin DD, Mowry JB, Beuhler MC, et al. 2021 Annual Report of the National Poison Data System© (NPDS) from America's Poison Centers: 39th Annual Report. Clin Toxicol (Phila) 2022; 60:1381.</a></li><li class="breakAll">United States Bureau of Labor Statistics. Injuries, Illnesses, and Fatalities. https://www.bls.gov/iif/fatal-injuries-tables.htm.</li><li><a class="nounderline abstract_t">Downs JW, Wills BK, Cumpston KL, Rose SR. Descriptive epidemiology of clinically significant occupational poisonings, United States, 2008-2018. Clin Toxicol (Phila) 2021; 59:1259.</a></li><li><a class="nounderline abstract_t">Michaels RA. Emergency planning and the acute toxic potency of inhaled ammonia. Environ Health Perspect 1999; 107:617.</a></li><li><a class="nounderline abstract_t">Lemiere C, Lavoie G, Doyen V, Vandenplas O. Irritant-Induced Asthma. J Allergy Clin Immunol Pract 2022; 10:2799.</a></li><li><a class="nounderline abstract_t">Amshel CE, Fealk MH, Phillips BJ, Caruso DM. Anhydrous ammonia burns case report and review of the literature. Burns 2000; 26:493.</a></li><li><a class="nounderline abstract_t">White CE, Park MS, Renz EM, et al. Burn center treatment of patients with severe anhydrous ammonia injury: case reports and literature review. J Burn Care Res 2007; 28:922.</a></li><li><a class="nounderline abstract_t">Dinis-Oliveira RJ, Carvalho F, Moreira R, et al. Clinical and forensic signs related to chemical burns: a mechanistic approach. Burns 2015; 41:658.</a></li><li><a class="nounderline abstract_t">Heidari H, Mohammadbeigi A, Soltanzadeh A, et al. Respiratory effects of occupational exposure to low concentration of hydrochloric acid among exposed workers: a case study in steel industry. Med Gas Res 2019; 9:208.</a></li><li><a class="nounderline abstract_t">Thickett KM, McCoach JS, Gerber JM, et al. Occupational asthma caused by chloramines in indoor swimming-pool air. Eur Respir J 2002; 19:827.</a></li><li><a class="nounderline abstract_t">Babu RV, Cardenas V, Sharma G. Acute respiratory distress syndrome from chlorine inhalation during a swimming pool accident: a case report and review of the literature. J Intensive Care Med 2008; 23:275.</a></li><li><a class="nounderline abstract_t">Habets JM, Geursen-Reitsma AM, Stolz E, van Joost T. Sensitization to sodium hypochlorite causing hand dermatitis. Contact Dermatitis 1986; 15:140.</a></li><li><a class="nounderline abstract_t">Tanen DA, Graeme KA, Raschke R. Severe lung injury after exposure to chloramine gas from household cleaners. N Engl J Med 1999; 341:848.</a></li><li><a class="nounderline abstract_t">White CW, Martin JG. Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc 2010; 7:257.</a></li><li><a class="nounderline abstract_t">Huynh Tuong A, Despréaux T, Loeb T, et al. Emergency management of chlorine gas exposure - a systematic review. Clin Toxicol (Phila) 2019; 57:77.</a></li><li><a class="nounderline abstract_t">Bosse GM. Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. J Toxicol Clin Toxicol 1994; 32:233.</a></li><li><a class="nounderline abstract_t">Aslan S, Kandiş H, Akgun M, et al. The effect of nebulized NaHCO3 treatment on "RADS" due to chlorine gas inhalation. Inhal Toxicol 2006; 18:895.</a></li><li><a class="nounderline abstract_t">Vinsel PJ. Treatment of acute chlorine gas inhalation with nebulized sodium bicarbonate. J Emerg Med 1990; 8:327.</a></li><li><a class="nounderline abstract_t">Douidar SM. Nebulized sodium bicarbonate in acute chlorine inhalation. Pediatr Emerg Care 1997; 13:406.</a></li><li><a class="nounderline abstract_t">Güloğlu C, Kara IH, Erten PG. Acute accidental exposure to chlorine gas in the Southeast of Turkey: a study of 106 cases. Environ Res 2002; 88:89.</a></li><li><a class="nounderline abstract_t">Cevik Y, Onay M, Akmaz I, Sezigen S. Mass casualties from acute inhalation of chlorine gas. South Med J 2009; 102:1209.</a></li><li><a class="nounderline abstract_t">Wang J, Zhang L, Walther SM. Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment. Intensive Care Med 2002; 28:352.</a></li><li><a class="nounderline abstract_t">Wang J, Winskog C, Edston E, Walther SM. Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs. Acta Anaesthesiol Scand 2005; 49:183.</a></li><li><a class="nounderline abstract_t">Gunnarsson M, Walther SM, Seidal T, Lennquist S. Effects of inhalation of corticosteroids immediately after experimental chlorine gas lung injury. J Trauma 2000; 48:101.</a></li><li><a class="nounderline abstract_t">Chester EH, Kaimal J, Payne CB Jr, Kohn PM. Pulmonary injury following exposure to chlorine gas. Possible beneficial effects of steroid treatment. Chest 1977; 72:247.</a></li><li><a class="nounderline abstract_t">Agabiti N, Ancona C, Forastiere F, et al. Short term respiratory effects of acute exposure to chlorine due to a swimming pool accident. Occup Environ Med 2001; 58:399.</a></li><li><a class="nounderline abstract_t">Moulick ND, Banavali S, Abhyankar AD, et al. Acute accidental exposure to chlorine fumes--a study of 82 cases. Indian J Chest Dis Allied Sci 1992; 34:85.</a></li><li><a class="nounderline abstract_t">Parimon T, Kanne JP, Pierson DJ. Acute inhalation injury with evidence of diffuse bronchiolitis following chlorine gas exposure at a swimming pool. Respir Care 2004; 49:291.</a></li><li><a class="nounderline abstract_t">Demnati R, Fraser R, Martin JG, et al. Effects of dexamethasone on functional and pathological changes in rat bronchi caused by high acute exposure to chlorine. Toxicol Sci 1998; 45:242.</a></li><li class="breakAll">The National Institute for Occupational Safety and Health (NIOSH). Phosgene. https://www.cdc.gov/niosh/topics/phosgene/default.html (Accessed on November 02, 2023).</li><li class="breakAll">National Research Council (US) Subcommittee on Acute Exposure Guideline Levels. Phosgene: Acute Exposure Guideline Levels. In: Acute Exposure Guideline Levels for Selected Airborne Chemicals, National Academies Press (US), Washington DC 2002. Vol 2.</li><li><a class="nounderline abstract_t">Vaish AK, Consul S, Agrawal A, et al. Accidental phosgene gas exposure: A review with background study of 10 cases. J Emerg Trauma Shock 2013; 6:271.</a></li><li><a class="nounderline abstract_t">Charan NB, Myers CG, Lakshminarayan S, Spencer TM. Pulmonary injuries associated with acute sulfur dioxide inhalation. Am Rev Respir Dis 1979; 119:555.</a></li><li><a class="nounderline abstract_t">Piirilä PL, Nordman H, Korhonen OS, Winblad I. A thirteen-year follow-up of respiratory effects of acute exposure to sulfur dioxide. Scand J Work Environ Health 1996; 22:191.</a></li><li><a class="nounderline abstract_t">Raja DS, Sultana B. Potential health hazards for students exposed to formaldehyde in the gross anatomy laboratory. J Environ Health 2012; 74:36.</a></li><li><a class="nounderline abstract_t">Dean AM, Secrest AM, Powell DL. Contact Urticaria From Occupational Exposure to Formaldehyde. Dermatitis 2016; 27:232.</a></li><li><a class="nounderline abstract_t">Pandey CK, Agarwal A, Baronia A, Singh N. Toxicity of ingested formalin and its management. Hum Exp Toxicol 2000; 19:360.</a></li><li><a class="nounderline abstract_t">Nishikawa A, Nagano K, Kojima H, Ogawa K. A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity. Regul Toxicol Pharmacol 2021; 123:104937.</a></li><li><a class="nounderline abstract_t">Eells JT, McMartin KE, Black K, et al. Formaldehyde poisoning. Rapid metabolism to formic acid. JAMA 1981; 246:1237.</a></li><li><a class="nounderline abstract_t">Spellman GG Sr. Formaldehyde poisoning successfully treated with hemodialysis. J Iowa Med Soc 1983; 73:175.</a></li><li><a class="nounderline abstract_t">Willis CM, Stephens JM, Wilkinson JD. Experimentally-induced irritant contact dermatitis. Determination of optimum irritant concentrations. Contact Dermatitis 1988; 18:20.</a></li><li class="breakAll">Agency for Toxic Substances and Disease Registry. Medical management guidelines for sodium hydroxide (NaOH). https://wwwn.cdc.gov/TSP/MMG/MMGDetails.aspx?mmgid=246&amp;toxid=45.</li><li><a class="nounderline abstract_t">Bernstein IL. Isocyanate-induced pulmonary diseases: a current perspective. J Allergy Clin Immunol 1982; 70:24.</a></li><li><a class="nounderline abstract_t">Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2002; 2:213.</a></li><li><a class="nounderline abstract_t">Bernstein JA. Overview of diisocyanate occupational asthma. Toxicology 1996; 111:181.</a></li><li><a class="nounderline abstract_t">Guidotti TL. Hydrogen sulfide intoxication. Handb Clin Neurol 2015; 131:111.</a></li><li><a class="nounderline abstract_t">Hendrickson RG, Chang A, Hamilton RJ. Co-worker fatalities from hydrogen sulfide. Am J Ind Med 2004; 45:346.</a></li><li><a class="nounderline abstract_t">Beck JF, Bradbury CM, Connors AJ, Donini JC. Nitrite as antidote for acute hydrogen sulfide intoxication? Am Ind Hyg Assoc J 1981; 42:805.</a></li><li><a class="nounderline abstract_t">Hall AH, Rumack BH. Hydrogen sulfide poisoning: an antidotal role for sodium nitrite? Vet Hum Toxicol 1997; 39:152.</a></li><li><a class="nounderline abstract_t">Smilkstein MJ, Bronstein AC, Pickett HM, Rumack BH. Hyperbaric oxygen therapy for severe hydrogen sulfide poisoning. J Emerg Med 1985; 3:27.</a></li><li><a class="nounderline abstract_t">Asif MJ, Exline MC. Utilization of hyperbaric oxygen therapy and induced hypothermia after hydrogen sulfide exposure. Respir Care 2012; 57:307.</a></li><li><a class="nounderline abstract_t">Rizzuto N, De Grandis D, Di Trapani G, Pasinato E. n-hexane polyneuropathy. An occupational disease of shoemakers. Eur Neurol 1980; 19:308.</a></li><li><a class="nounderline abstract_t">Passero S, Battistini N, Cioni R, et al. Toxic polyneuropathy of shoe workers in Italy. A clinical, neurophysiological and follow-up study. Ital J Neurol Sci 1983; 4:463.</a></li><li><a class="nounderline abstract_t">Filley CM, Halliday W, Kleinschmidt-DeMasters BK. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 2004; 63:1.</a></li><li><a class="nounderline abstract_t">King MD. Neurological sequelae of toluene abuse. Hum Toxicol 1982; 1:281.</a></li><li><a class="nounderline abstract_t">Ikeda M, Ohtsuji H. Significance of urinary hippuric acid determination as an index of toluene exposure. Br J Ind Med 1969; 26:244.</a></li><li><a class="nounderline abstract_t">Inoue O, Kanno E, Kasai K, et al. Benzylmercapturic acid is superior to hippuric acid and o-cresol as a urinary marker of occupational exposure to toluene. Toxicol Lett 2004; 147:177.</a></li><li><a class="nounderline abstract_t">Akpan E, Moffat I, Abara U. Analytical data on respiratory symptoms and pulmonary impairments due to exposure to non-combusted liquefied petroleum gas. Data Brief 2021; 36:107106.</a></li><li><a class="nounderline abstract_t">Rudzki E, Kozlowska A. Causes of chromate dermatitis in Poland. Contact Dermatitis 1980; 6:191.</a></li><li><a class="nounderline abstract_t">Antonini JM, Lewis AB, Roberts JR, Whaley DA. Pulmonary effects of welding fumes: review of worker and experimental animal studies. Am J Ind Med 2003; 43:350.</a></li><li><a class="nounderline abstract_t">Greenberg MI, Vearrier D. Metal fume fever and polymer fume fever. Clin Toxicol (Phila) 2015; 53:195.</a></li></ol></div><div id="topicVersionRevision">Topic 141272 Version 2.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36602072" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2021 Annual Report of the National Poison Data System©(NPDS) from America's Poison Centers: 39th Annual Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36602072" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2021 Annual Report of the National Poison Data System©(NPDS) from America's Poison Centers: 39th Annual Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33703981" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Descriptive epidemiology of clinically significant occupational poisonings, United States, 2008-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10417358" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Emergency planning and the acute toxic potency of inhaled ammonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35820617" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Irritant-Induced Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10812276" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Anhydrous ammonia burns case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17925646" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Burn center treatment of patients with severe anhydrous ammonia injury: case reports and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25280586" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical and forensic signs related to chemical burns: a mechanistic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31898605" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Respiratory effects of occupational exposure to low concentration of hydrochloric acid among exposed workers: a case study in steel industry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12030720" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Occupational asthma caused by chloramines in indoor swimming-pool air.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18508837" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Acute respiratory distress syndrome from chlorine inhalation during a swimming pool accident: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3780214" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sensitization to sodium hypochlorite causing hand dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10490389" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Severe lung injury after exposure to chloramine gas from household cleaners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20601629" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30672349" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Emergency management of chlorine gas exposure - a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8007031" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16864407" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The effect of nebulized NaHCO3 treatment on "RADS" due to chlorine gas inhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2165079" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Treatment of acute chlorine gas inhalation with nebulized sodium bicarbonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9435003" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Nebulized sodium bicarbonate in acute chlorine inhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11908933" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Acute accidental exposure to chlorine gas in the Southeast of Turkey: a study of 106 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20016425" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mass casualties from acute inhalation of chlorine gas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11904667" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15715619" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647573" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Effects of inhalation of corticosteroids immediately after experimental chlorine gas lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/884993" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pulmonary injury following exposure to chlorine gas. Possible beneficial effects of steroid treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11351056" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Short term respiratory effects of acute exposure to chlorine due to a swimming pool accident.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1459667" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute accidental exposure to chlorine fumes--a study of 82 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14982650" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute inhalation injury with evidence of diffuse bronchiolitis following chlorine gas exposure at a swimming pool.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9848131" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Effects of dexamethasone on functional and pathological changes in rat bronchi caused by high acute exposure to chlorine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9848131" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Effects of dexamethasone on functional and pathological changes in rat bronchi caused by high acute exposure to chlorine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9848131" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effects of dexamethasone on functional and pathological changes in rat bronchi caused by high acute exposure to chlorine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24339660" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Accidental phosgene gas exposure: A review with background study of 10 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/443628" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Pulmonary injuries associated with acute sulfur dioxide inhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8837264" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A thirteen-year follow-up of respiratory effects of acute exposure to sulfur dioxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22329207" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Potential health hazards for students exposed to formaldehyde in the gross anatomy laboratory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27427823" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Contact Urticaria From Occupational Exposure to Formaldehyde.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10962510" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Toxicity of ingested formalin and its management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33905780" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7265415" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Formaldehyde poisoning. Rapid metabolism to formic acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6863996" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Formaldehyde poisoning successfully treated with hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3349774" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Experimentally-induced irritant contact dermatitis. Determination of optimum irritant concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3349774" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Experimentally-induced irritant contact dermatitis. Determination of optimum irritant concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6282949" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Isocyanate-induced pulmonary diseases: a current perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11811926" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Diisocyanate asthma: clinical aspects and immunopathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8711734" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Overview of diisocyanate occupational asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26563786" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hydrogen sulfide intoxication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15029566" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Co-worker fatalities from hydrogen sulfide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7315740" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Nitrite as antidote for acute hydrogen sulfide intoxication?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9167244" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Hydrogen sulfide poisoning: an antidotal role for sodium nitrite?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4093555" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Hyperbaric oxygen therapy for severe hydrogen sulfide poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22004989" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Utilization of hyperbaric oxygen therapy and induced hypothermia after hydrogen sulfide exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6249607" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : n-hexane polyneuropathy. An occupational disease of shoemakers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6674248" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Toxic polyneuropathy of shoe workers in Italy. A clinical, neurophysiological and follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14748556" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The effects of toluene on the central nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7173909" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Neurological sequelae of toluene abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5794951" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Significance of urinary hippuric acid determination as an index of toluene exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14757321" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Benzylmercapturic acid is superior to hippuric acid and o-cresol as a urinary marker of occupational exposure to toluene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34307804" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Analytical data on respiratory symptoms and pulmonary impairments due to exposure to non-combusted liquefied petroleum gas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6446436" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Causes of chromate dermatitis in Poland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12645092" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Pulmonary effects of welding fumes: review of worker and experimental animal studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25706449" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Metal fume fever and polymer fume fever.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
